They do not operate in a market, but there are market-driven pressures for developing new drugs: efficient companies assign research priority according to their

They do not operate in a market, but there are market-driven pressures for developing new drugs: efficient companies assign research priority according to their expected returns from drug development. In any case, reform is definitively needed; and complaining without demanding reform is pointless. Discovering new drugs is a scientific endeavor and so it really should be as open as possible. I am a little skeptical of plain massive government research agencies, but maybe it's a good way to go. Maybe patent reform or something else is instead better. If you look at machine learning research the industry is not bad at sharing results because of two factors, apparently: 1) Companies know that progress will be much faster if everyone decides to share 2) To attract to researchers, they need to show they do high caliber research and share.